Prostaglandin E2 inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors

Ying Ji Li, Xing Qi Wang, Tadashi Sato, Nobuhiro Kanaji, Masanori Nakanishi, Miok Kim, Joel Michalski, Amy J. Nelson, Jian Hong Sun, Maha Farid, Hesham E Basma, Amol N Patil, Myron Lee Toews, Xiang-de Liu, Stephen I. Rennard

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The migration of fibroblasts is believed to play a key role in both normal wound repair and abnormal tissue remodeling. Prostaglandin E (PGE)2, a mediator that can inhibit many fibroblast functions including chemotaxis, was reported to be mediated by the E-prostanoid (EP) receptor EP2. PGE2, however, can act on four receptors. This study was designed to determine if EP receptors, in addition to EP2, can modulate fibroblast chemotaxis. Using human fetal lung fibroblasts, the expression of all four EP receptors was demonstrated by Western blotting. EP2-selective and EP4-selective agonists inhibited both chemotaxis toward fibronectin in the blindwell assay and migration in a wound-closure assay. In contrast, EP1-selective and EP3-selective agonists stimulated cell migration in both assay systems. These results were confirmed using EP-selective antagonists. The role of both EP2 and EP4 receptors in mediating the PGE2 inhibition of chemotaxis was also confirmed by small interfering RNA suppression. Furthermore, the role of EP receptors was confirmed by blocking the expected signaling pathways. Taken together, these results demonstrate that PGE2 can act on multiple EP receptors in human lung fibroblasts, to exert disparate effects. Alterations in EP receptor expression may have the potential to alter PGE2 action. Targeting specific EP receptors may offer therapeutic opportunities in conditions characterized by abnormal tissue repair and remodeling.

Original languageEnglish (US)
Pages (from-to)99-107
Number of pages9
JournalAmerican journal of respiratory cell and molecular biology
Volume44
Issue number1
DOIs
StatePublished - Jan 1 2010

Fingerprint

Chemotaxis
Fibroblasts
Dinoprostone
Prostaglandins
Lung
Assays
Receptors, Prostaglandin E, EP2 Subtype
Repair
Cell Migration Inhibition
Tissue
Wounds and Injuries
Prostaglandins E
Fibronectins
Small Interfering RNA
Cell Movement
Western Blotting

Keywords

  • Cell migration
  • EP receptors
  • Human lung fibroblast

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Prostaglandin E2 inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors. / Li, Ying Ji; Wang, Xing Qi; Sato, Tadashi; Kanaji, Nobuhiro; Nakanishi, Masanori; Kim, Miok; Michalski, Joel; Nelson, Amy J.; Sun, Jian Hong; Farid, Maha; Basma, Hesham E; Patil, Amol N; Toews, Myron Lee; Liu, Xiang-de; Rennard, Stephen I.

In: American journal of respiratory cell and molecular biology, Vol. 44, No. 1, 01.01.2010, p. 99-107.

Research output: Contribution to journalArticle

Li, Ying Ji ; Wang, Xing Qi ; Sato, Tadashi ; Kanaji, Nobuhiro ; Nakanishi, Masanori ; Kim, Miok ; Michalski, Joel ; Nelson, Amy J. ; Sun, Jian Hong ; Farid, Maha ; Basma, Hesham E ; Patil, Amol N ; Toews, Myron Lee ; Liu, Xiang-de ; Rennard, Stephen I. / Prostaglandin E2 inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors. In: American journal of respiratory cell and molecular biology. 2010 ; Vol. 44, No. 1. pp. 99-107.
@article{4ef9239522654c21951acd3c3d423588,
title = "Prostaglandin E2 inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors",
abstract = "The migration of fibroblasts is believed to play a key role in both normal wound repair and abnormal tissue remodeling. Prostaglandin E (PGE)2, a mediator that can inhibit many fibroblast functions including chemotaxis, was reported to be mediated by the E-prostanoid (EP) receptor EP2. PGE2, however, can act on four receptors. This study was designed to determine if EP receptors, in addition to EP2, can modulate fibroblast chemotaxis. Using human fetal lung fibroblasts, the expression of all four EP receptors was demonstrated by Western blotting. EP2-selective and EP4-selective agonists inhibited both chemotaxis toward fibronectin in the blindwell assay and migration in a wound-closure assay. In contrast, EP1-selective and EP3-selective agonists stimulated cell migration in both assay systems. These results were confirmed using EP-selective antagonists. The role of both EP2 and EP4 receptors in mediating the PGE2 inhibition of chemotaxis was also confirmed by small interfering RNA suppression. Furthermore, the role of EP receptors was confirmed by blocking the expected signaling pathways. Taken together, these results demonstrate that PGE2 can act on multiple EP receptors in human lung fibroblasts, to exert disparate effects. Alterations in EP receptor expression may have the potential to alter PGE2 action. Targeting specific EP receptors may offer therapeutic opportunities in conditions characterized by abnormal tissue repair and remodeling.",
keywords = "Cell migration, EP receptors, Human lung fibroblast",
author = "Li, {Ying Ji} and Wang, {Xing Qi} and Tadashi Sato and Nobuhiro Kanaji and Masanori Nakanishi and Miok Kim and Joel Michalski and Nelson, {Amy J.} and Sun, {Jian Hong} and Maha Farid and Basma, {Hesham E} and Patil, {Amol N} and Toews, {Myron Lee} and Xiang-de Liu and Rennard, {Stephen I.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1165/rcmb.2009-0163OC",
language = "English (US)",
volume = "44",
pages = "99--107",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Prostaglandin E2 inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors

AU - Li, Ying Ji

AU - Wang, Xing Qi

AU - Sato, Tadashi

AU - Kanaji, Nobuhiro

AU - Nakanishi, Masanori

AU - Kim, Miok

AU - Michalski, Joel

AU - Nelson, Amy J.

AU - Sun, Jian Hong

AU - Farid, Maha

AU - Basma, Hesham E

AU - Patil, Amol N

AU - Toews, Myron Lee

AU - Liu, Xiang-de

AU - Rennard, Stephen I.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The migration of fibroblasts is believed to play a key role in both normal wound repair and abnormal tissue remodeling. Prostaglandin E (PGE)2, a mediator that can inhibit many fibroblast functions including chemotaxis, was reported to be mediated by the E-prostanoid (EP) receptor EP2. PGE2, however, can act on four receptors. This study was designed to determine if EP receptors, in addition to EP2, can modulate fibroblast chemotaxis. Using human fetal lung fibroblasts, the expression of all four EP receptors was demonstrated by Western blotting. EP2-selective and EP4-selective agonists inhibited both chemotaxis toward fibronectin in the blindwell assay and migration in a wound-closure assay. In contrast, EP1-selective and EP3-selective agonists stimulated cell migration in both assay systems. These results were confirmed using EP-selective antagonists. The role of both EP2 and EP4 receptors in mediating the PGE2 inhibition of chemotaxis was also confirmed by small interfering RNA suppression. Furthermore, the role of EP receptors was confirmed by blocking the expected signaling pathways. Taken together, these results demonstrate that PGE2 can act on multiple EP receptors in human lung fibroblasts, to exert disparate effects. Alterations in EP receptor expression may have the potential to alter PGE2 action. Targeting specific EP receptors may offer therapeutic opportunities in conditions characterized by abnormal tissue repair and remodeling.

AB - The migration of fibroblasts is believed to play a key role in both normal wound repair and abnormal tissue remodeling. Prostaglandin E (PGE)2, a mediator that can inhibit many fibroblast functions including chemotaxis, was reported to be mediated by the E-prostanoid (EP) receptor EP2. PGE2, however, can act on four receptors. This study was designed to determine if EP receptors, in addition to EP2, can modulate fibroblast chemotaxis. Using human fetal lung fibroblasts, the expression of all four EP receptors was demonstrated by Western blotting. EP2-selective and EP4-selective agonists inhibited both chemotaxis toward fibronectin in the blindwell assay and migration in a wound-closure assay. In contrast, EP1-selective and EP3-selective agonists stimulated cell migration in both assay systems. These results were confirmed using EP-selective antagonists. The role of both EP2 and EP4 receptors in mediating the PGE2 inhibition of chemotaxis was also confirmed by small interfering RNA suppression. Furthermore, the role of EP receptors was confirmed by blocking the expected signaling pathways. Taken together, these results demonstrate that PGE2 can act on multiple EP receptors in human lung fibroblasts, to exert disparate effects. Alterations in EP receptor expression may have the potential to alter PGE2 action. Targeting specific EP receptors may offer therapeutic opportunities in conditions characterized by abnormal tissue repair and remodeling.

KW - Cell migration

KW - EP receptors

KW - Human lung fibroblast

UR - http://www.scopus.com/inward/record.url?scp=78650640662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650640662&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2009-0163OC

DO - 10.1165/rcmb.2009-0163OC

M3 - Article

VL - 44

SP - 99

EP - 107

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 1

ER -